Ethical Implications of HIV Pre-Exposure Prophylaxis (PrEP) for African American Women and Adolescent Girls

views comments

Faith E. Fletcher, PhD, MA
Assistant Professor
Division of Community Health Sciences
University of Illinois at Chicago
Recorded February 17, 2016

Pre Exposure Prophylaxis (PrEP) is a new HIV prevention strategy approved by the Food and Drug Administration for use by uninfected, high-risk adult populations. PrEP’s potential as an HIV preventive strategy/biomedical method for adolescents is unknown. The presentation will present preliminary results from a study that examined benefits, barriers, and ethical concerns associated with Pre-exposure Prophylaxis (PrEP) utilization and clinical trial participation among African American adolescent girls. Study findings have the potential to generate evidence-based data to inform HIV research ethics practices and increase just and fair access to HIV scientific advances.

This lecture was part of the 2015-2016 Bioethics Brownbag & Webinar Series, presented by the Center for Ethics.

Tags

Ethical Implications of HIV Pre-Exposure Prophylaxis (PrEP) for African American Women and Adolescent Girls

Related Media